RLAY
Relay Therapeutics, Inc.
Stock
$18.96+0.47 (+2.54%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $121M | $84M | $124M | $144M | $152M | $280M | $448M | $42M |
| Current assets | $928M | $578M | $809M | $770M | $1.0B | $976M | $770M | $361M |
| Intangible assets | — | — | — | $2.3M | $2.3M | $2.3M | — | — |
| Total assets | $967M | $621M | $871M | $844M | $1.1B | $1.0B | $800M | $393M |
| Current liabilities | $51M | $26M | $51M | $30M | $64M | $24M | $14M | $12M |
| Total liabilities | $77M | $54M | $94M | $92M | $150M | $111M | $37M | $36M |
| Shareholders' equity | $890M | $567M | $778M | $752M | $950M | $898M | $763M | −$180M |
| Shares outstanding | 219.1M | 178.7M | 169.5M | 131.2M | 121.4M | 108.3M | 90.4M | — |
| Current ratio | 18.27 | 22.61 | 15.95 | 25.44 | 16.00 | 40.14 | 56.49 | 30.08 |